文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛消化、代谢与肾脏急症

安全网医院内科ICU中COVID-19肺炎患者的死亡原因

Causes of Death Among Medical ICU Patients With Pneumonia Due to COVID-19 in a Safety-Net Hospital.
PubMed 文献 · Crit Care Explor · 2023-07-14
一句话结论回顾性单中心队列显示,COVID-19内科ICU死亡患者主要死因为急性呼吸衰竭(57.8%),三波疫情间无显著变化。

该研究为2020年3月至2021年12月洛杉矶一家600张床三级医院内科ICU的回顾性单中心队列研究,纳入306例因症状性COVID-19住院死亡的患者。主要死因为呼吸衰竭(57.8%),三波疫情间无显著变化;脓毒症为第二位死因(23.9%),从野生型波至德尔塔波显著下降,其中22%(n=16)与真菌血症相关。激素使用与死因无显著关联。作者指出该结果与非COVID-19急性呼吸窘迫综合征的死亡原因报告不同,并发现5%患者主要死于真菌血症,为进一步研究提供了方向。

要点

  • 306例COVID-19住院死亡患者中,主要死因为呼吸衰竭,占57.8%,三波疫情间无显著变化。
  • 脓毒症为第二位死因,占23.9%,从野生型波至德尔塔波显著下降。
  • 以脓毒症为死因的患者中,22%(n=16)与真菌血症相关;作者指出5%患者主要死于真菌血症。
  • 激素给药与死因之间无显著关联。
  • 阿尔法/埃普西隆波(2020年12月至2021年5月)死亡率最高,与野生型或德尔塔波相比。

适用人群与场景

  • 2020年3月至2021年12月入住洛杉矶一家600张床三级医院内科ICU的成人(n=306)症状性COVID-19住院死亡患者。

研究设计与关键结果

  • 研究类型:回顾性单中心队列研究,时间2020年3月至2021年12月,地点为洛杉矶一家600张床三级医院的内科ICU。
  • 人群:成人(n=306)因症状性COVID-19入住ICU并在院内死亡的患者;86.3%为西班牙裔/拉丁裔。
  • 主要死因:呼吸衰竭,占57.8%;三波疫情(野生型、阿尔法/埃普西隆、德尔塔)间肺部死亡比例无显著变化。
  • 症状出现至入院平均时间6.5天,平均住院时长18天;肺部死因与其他死因之间无差异。
  • 第二位死因:脓毒症,占23.9%,从野生型波至德尔塔波显著下降。
  • 以脓毒症为死因的患者中,22%(n=16)与真菌血症相关;作者指出5%患者主要死于真菌血症。
  • 激素给药与死因之间无显著关联。
  • 阿尔法/埃普西隆波(2020年12月至2021年5月)死亡率最高,与野生型或德尔塔波相比。

证据类型、等级与局限

  • 证据类型:回顾性单中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,COVID-19 ICU死亡患者主要死因为急性呼吸衰竭,三波疫情间无显著变化,这与非COVID-19急性呼吸窘迫综合征的死亡原因报告不同。
  • 作者指出,5%患者主要死于真菌血症,为进一步研究提供了方向。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: We sought to identify the primary causes of death of adult patients admitted to the medical ICU with symptomatic COVID-19 who ultimately suffered in-hospital mortality over the span of three major waves of COVID-19: Wild-type, alpha/epsilon, and delta.

DESIGN: Retrospective single-center cohort study from March 2020 to December 2021.

SETTING: One medical ICU in a 600-bed Tertiary Care Hospital in Los Angeles, CA.

PATIENTS: Adult (n = 306) ICU patients admitted with symptomatic COVID-19 who suffered in-hospital mortality.

INTERVENTIONS: None.

MAIN RESULTS: Of the 306 patients with COVID-19 who died in the hospital, 86.3% were Hispanic/Latino. The leading cause of death was respiratory failure, occurring in 57.8% of patients. There was no significant change in the rate of pulmonary deaths across the three waves of COVID-19 in our study period. The mean time from symptom onset to admission was 6.5 days, with an average hospital length of stay of 18 days. This did not differ between pulmonary and other causes of death. Sepsis was the second most common cause of death at 23.9% with a significant decrease from the wild-type wave to the delta wave. Among patients with sepsis as the cause of death, 22% (n = 16) were associated with fungemia. There was no significant association between steroid administration and cause of death. Lastly, the alpha/epsilon wave from December 2020 to May 2021 had the highest mortality rate when compared with wild-type or delta waves.

CONCLUSIONS: We found the primary cause of death in ICU patients with COVID-19 was acute respiratory failure, without significant changes over the span of three waves of COVID-19. This finding contrasts with reported causes of death for patients with non-COVID-19 acute respiratory distress syndrome, in which respiratory failure is an uncommon cause of death. In addition, we identified a subset of patients (5%) who died primarily due to fungemia, providing an area for further investigation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Cannizzo JP, Chai AL, Do CT, et al. Causes of Death Among Medical ICU Patients With Pneumonia Due to COVID-19 in a Safety-Net Hospital. Crit Care Explor. 2023. PMID: 37465700. doi:10.1097/CCE.0000000000000947

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。